Frontiers of COVID-19
122,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
61 °P sammeln
  • Gebundenes Buch

This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of "herd immunity" and explore the current vaccine trials taking place in different countries. This…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
This book aims to serve the critical interests of the global community by supplying the most current knowledge and understanding of Covid-19 epidemiology, treatment, and prognoses. There was much uncertain and contradictory information published in the first year of the novel coronavirus. The dynamics of COVID-19 have now been realized, including the type of antibodies produced in infected patients and their limited lasting endurance. This book will set the record straight on the concept of "herd immunity" and explore the current vaccine trials taking place in different countries. This comprehensive book will illuminate recent advances regarding COVID-19 and offer a possible roadmap on how to move forward.

Frontiers of COVID-19: A Pathophysiology and Epidemiology Roadmap of Novel Coronavirus Disease will be a vital and forward-looking guide for infectious disease clinicians, scientists and researchers, and students at the graduate level.

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Sasan Adibi, PhD, Senior Member, IEEE School of IT Deakin University Melbourne, Australia   A/Prof Paul Griffin B.Sc. (Hons), MBBS, FRACP, FRCPA, FACTM School of Medicine, University of Queensland, Queensland, Australia Department of Infectious Diseases, Mater Health, Queensland, Australia Melvin Sanicas, MD, MSc, FRSPH, FRSA Senior Medical Director, Global Medical Affairs Clover Biopharmaceuticals Zurich, Switzerland Maryam Rashidi, MD, PhD Senior Postdoctoral Researcher Immunology and Inflammation Walter & Eliza Hall Institute of Medical Research (WEHI) Melbourne, Australia Francesco Lanfranchi, MD Nuclear Medicine Unit Department of Health Sciences (DISSAL) University of Genoa Genoa, Italy